Phlebology Vein Surgery and Ultrasonography Diagnosis and Management of Venous Disease
Anticoagulation for venous thromboembolism
Publication
, Chapter
Ortel, TL
January 1, 2014
Anticoagulation is a fundamental of management in venous disease. This chapter discusses anticoagulant therapy and a variety of agents. The current treatment for a new venous thromboembolic event in a patient is anticoagulant therapy, beginning with either unfractionated heparin (UFH) or low-molecular-weight heparin (LMWH), while warfarin is concomitantly initiated for chronic therapy.
Duke Scholars
Citation
APA
Chicago
ICMJE
MLA
NLM
Ortel, T. L. (2014). Anticoagulation for venous thromboembolism. In Phlebology Vein Surgery and Ultrasonography Diagnosis and Management of Venous Disease (pp. 293–307). https://doi.org/10.1007/978-3-319-01812-6_21
Ortel, T. L. “Anticoagulation for venous thromboembolism.” In Phlebology Vein Surgery and Ultrasonography Diagnosis and Management of Venous Disease, 293–307, 2014. https://doi.org/10.1007/978-3-319-01812-6_21.
Ortel TL. Anticoagulation for venous thromboembolism. In: Phlebology Vein Surgery and Ultrasonography Diagnosis and Management of Venous Disease. 2014. p. 293–307.
Ortel, T. L. “Anticoagulation for venous thromboembolism.” Phlebology Vein Surgery and Ultrasonography Diagnosis and Management of Venous Disease, 2014, pp. 293–307. Scopus, doi:10.1007/978-3-319-01812-6_21.
Ortel TL. Anticoagulation for venous thromboembolism. Phlebology Vein Surgery and Ultrasonography Diagnosis and Management of Venous Disease. 2014. p. 293–307.